Abstract
To help identify factors influencing age-related cognitive decline and disease, a web-based simple visual reaction time (RT and svRT respectively, index of processing speed) and paired-associate learning (PAL, indexing of verbal episodic memory) task were implemented. Test results were combined with 22 survey questions. An analysis of RT and svTR data from the MindCrowd (n=75,666) cohort revealed education and reported stroke as potential modifiers of age-associated processing speed and memory decline. As a complement, we evaluated complex, recognition, reaction time (cvrRT) in the UK Biobank cohort and compared the results to a subset of the MindCrowd cohort, creating UKBb MindCrowd (n=39,795), mirroring the UK Biobank’s (n=158,247) age range (40-70y). Many estimates from an identical linear model, used for both cohorts, were similar despite noted cohort differences (e.g., USA vs. the UK). Results from the UK Biobank that differed from UKBb MindCrowd included a first-degree family history Alzheimer’s disease (FHAD) associated with slower cvrRTs and that sex and education affected age-related cvrRT slowing. While results from UKBb MindCrowd suggested that education and smoking status were related to opposite effects on age-related svRT slowing. MindCrowd’s collected RT and PAL findings have begun to pull back the curtain on the intricate network connecting processing speed, memory, and cognition to healthy and pathological brain aging.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors wish to acknowledge the Mueller Family Charitable Trust for funding the initial creation of the MindCrowd site and Mike Mueller for his significant donation of personal time during the development, testing, and ongoing evolution of the study. This work was also supported in part by the State of Arizona DHS in support of the Arizona Alzheimer's Consortium (PI; Eric Reiman), the Flinn Foundation (PI; Matt Huentelman), The McKnight Brain Research Foundation, NIH-NIA grant R01-AG049465 (PI; Carol Barnes), and NIH-NIA grants UH2 AG064706, U19 AG023122, U24 AG051129, and U24 AG051129-04S1 (PI; Nicholas J. Schork) We also acknowledge the support of many anonymous individual donors and institutional support of TGen, City of Hope, and the University of Arizona. Philanthropic fundraising efforts for MindCrowd were led by the TGen Foundation staff (Erin Massey, Chief Development Officer).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for this study was obtained from the Western Institutional Review Board (WIRB study number 1129241).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are being filtered to exclude irrelevant data fields and will be made available ASAP on Dryad (https://datadryad.org).